Cargando…
Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
BACKGROUND: The use of liver transplantation (LT) in patients with stage IV neuroendocrine pancreatic tumors (pan-NET) is under debate. Previous studies report a 5-year survival of 27–53% after LT in pan-NET and up to 92.7% in patients with mixed NETs. This study aimed to determine survival rates of...
Autores principales: | Kjaer, Josefine, Smith, Sara, Hellman, Per, Stålberg, Peter, Crona, Joakim, Welin, Staffan, Norlén, Olov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803729/ https://www.ncbi.nlm.nih.gov/pubmed/36175647 http://dx.doi.org/10.1007/s00268-022-06736-1 |
Ejemplares similares
-
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
por: Kjaer, Josefine, et al.
Publicado: (2022) -
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018) -
Invited Commentary: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
por: Borel Rinkes, Inne H. M.
Publicado: (2022) -
Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases
por: Kjaer, J, et al.
Publicado: (2021) -
Preoperative (68)Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions
por: Norlén, Olov, et al.
Publicado: (2017)